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Cell Proliferation and Chemical
Carcinogenesis: Conference Summary
and Future Directions
by James A. Swenberg
Although it has been acknowledged for many years
that cell proliferation is essential for carcinogenesis,
this is the first meeting to directly focus on its role in
carcinogenesis in a comprehensive manner. Many of
the critical issues were outlined by Dr. Melnick in his
opening remarks. Of particular interest is what data
can be brought to bear on the recent controversies
regarding the role of cell proliferation in studies of
nongenotoxic carcinogens tested at maximum tolerat-
ed doses (MTD), and can cell proliferation alone be a
cause of cancer? The symposium talks and poster pre-
sentations have been comprehensive and highly illumi-
nating. It is impossible to truly summarize such a
meeting, but I will try to place some ofthe major issues
in perspective.
Speakers at this meeting have frequently referred to
the multistep process ofcarcinogenesis. Many chemical
carcinogens require metabolic activation to produce
reactive electrophiles. Genotoxic agents directly dam-
age DNA, whereas other chemicals may generate free
radicals and indirectly damage DNA. In addition,
spontaneous or background damage to DNA is always
present. None of this DNA damage becomes a muta-
tion unless cell replication takes place. This cell repli-
cation can be the de novo replication ofa particular tis-
sue or cell type, it can be modulated either up or down
by toxicity, or it may be influenced by exposure to
exogenous agents such as promoters. After fixation of
such damage in the form of mutations at critical sites
in the genome, we have the very first step in carcino-
genesis, the initiated cell. In the past, we have focused
primarily on point mutations; however, it is now
known that chromosomal changes, such as insertions,
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deletions, rearrangements, and gene amplification play
important roles. One ofthe areas for future direction is
to increase our ability to look at such end points.
Initiated cells, however, are not cancer. They must
undergo selection pressures and clonal expansion.
Cancer is a probabilistic disease, and it requires mul-
tiple mutational events. The probability ofthis happen-
ing is greatly enhanced through clonal expansion. Ifwe
look more closely at the events occurring in a cell or
tissue after chemical exposure, it is clear that changes
in the balance between metabolic activation and detox-
ication will occur at different places in the dose-
response curve (1). In some cases metabolic activation
will be saturated at high doses, leading to a supralinear
dose response (Fig. 1, curve b). Two well-known exam-
ples of this type of response are vinyl chloride and (4-
(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
(NNK). If only high-dose data were used in assessing
risk to this type of response, risk would be underesti-
mated. With other compounds, detoxication or DNA
repair saturates at high doses (Fig. 1, curve c), in
which case the risk associated with low doses would be
overestimated. These generalizations are further
affected by dose-related changes in cell proliferation.
Whether the promutagenic lesion in DNA is the bio-
logically effective dose ofthe genotoxic chemical under
test or background DNA damage, it does not become a
mutation unless cell proliferation occurs. Cell prolifera-
tion is also a dose-related phenomenon that will affect
extrapolation ofrisk. Ifwe are to advance the scientific
underpinning of risk assessment, it will be important
to avoid making statements that are all-encompassing
and instead refer to data on specific compounds and
specific relationships.
To better understand the role of cell proliferation in
carcinogenesis, we need to consider the sources of
mutation. Figure 2 is a modification of Loeb's scheme
for the sources of human mutation (2). Endogenous
forms of DNA damage, free radicals, and polymerase
errors are constantly present in all cells of the body.
Regardless ofwhether these arise from endogenous orJ. A. SWENBERG
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FIGURE 1. Schematic of theoretical dose-response curves. Curve a
denotes a linear response, when biotransformation and DNA
repair enzymes are not saturated. Curve b represents a supralin-
ear response that results from saturation of metabolic activation.
Curve c depicts a sublinear response that can arise when detoxi-
cation or DNA repair is saturated.
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FIGURE 2. Mutations arise from endogenous and exogenous factors
that are modulated by DNA repair and replication. Modified from
Loeb (2).
exogenous processes, they are subject to DNA repair.
Only those forms of DNA damage that pass through
this filter of DNA repair and are present during cell
replication will lead to mutations. This is true whether
it is background DNA damage or chemically induced
DNA damage.
If one examines the amount of background DNA
damage present in cells, one finds background damage
is enormous. Table 1 provides estimates from a recent
report of the National Academy of Science (3). One
type of damage that may be an important mechanism
for mutations in p53 is the deamination of cytosine.
Likewise, apurinic sites and oxidative damage can lead
to the types ofmutations being found inp53. Ifwe look
at the amounts of these types of DNA damage, the
estimates range from 50,000 to 250,000 events per cell
Table 1. Approximate rates ofendogenous DNA damage
per cell per day (3).
Type ofdamage Amount
Depurination 24,000
Depyrimidination 1,300
Cytosine deamination 400
Single-strand breaks 120,000
N-7-methylguanine 84,000
06-methylguanine 3,000
Oxidation products 3,000
per day. Normally, the cell has very good DNA repair
systems available to correct these background lesions.
It should be recognized that when cell proliferation
increases, the time available for repairing DNA dam-
age decreases, whether the damage is endogenous or
exogenous.
In addition to its role in initiation, cell replication is
also important in clonal expansion. A cell that has a
single hit will have to be clonally expanded to the point
that the probability ofa second genetic event becomes
likely. Cell replication is a key factor in this expansion
ofthe initiated cell population. Ifwe are dealing with a
genotoxic agent, the probability of that second event
occurring happens with a much smaller population of
initiated cells than ifwe are dealing with DNA adducts
that are much rarer or that have a much lower efficien-
cy for causing mutations. Therefore, we should not
expect equal effects for the role of cell replication
across the broad range of chemicals examined for car-
cinogenic potential. However, there can be little doubt
that the more we know about the type and amount of
DNA damage, coupled with the extent ofcell prolifera-
tion, the more likely we can incorporate science into
the risk assessment process and improve its accuracy.
Two examples illustrate the role of cell proliferation
in carcinogenesis. Formaldehyde is a chemical for
which there has been great deal ofresearch conducted
to understand the mechanisms responsible for a highly
nonlinear dose response. For instance, we know from
the research of Heck et al. (4) that the extent of DNA
protein cross-linking per ppm of formaldehyde is
markedly decreased at concentrations below 6 ppm.
Between 6 and 15 ppm, the dose to DNA is linear. Yet,
this is the observable portion of the concentration-
response curve for nasal cancer that is highly nonlin-
ear, i.e., a 50-fold increase in cancer for a 2.5-fold
increase in dose (Fig. 3). Data from the new mecha-
nisms-based bioassay reported at this meeting (5)
replicates the initial bioassay, but has an additional
important exposure group of 10 ppm. This provides
new information on the concentration response for
tumor induction and clearly demonstrates that the
nonlinear response is a straight line from 6 to 15 ppm.
The other three lines in Figure 3 present cell prolifera-
tion data at various time points in this study. What is
clear from these data is that sustained increases in cell
proliferation exhibit virtually the same concentration
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FIGURE 3. Tumor incidence and cell proliferation in rats exposed to
formaldehyde. See Monticello et al. (5) for details.
response as the induction of squamous cell carcinomas.
It is almost inconceivable that cell replication is not the
driving factor for the induction ofnasal cancer because
we know that the molecular dose to DNA is linear over
this portion of the concentration response curve. This
provides strong evidence that sustained increases in
cell proliferation play a major role in determining the
dose response for tumor induction, and as such they
should be factored into risk assessment.
d-Limonene is the other example I would like to
highlight. Table 2 demonstrates that d-limonene caus-
es a 4- to 5-fold increase in cell proliferation in the
epithelial cells of the proximal tubules in the male
Fischer rat, a strain of rat that makes a2u-globulin, but
that no increase in cell proliferation occurs in the NBR
rat, which does not synthesize x2u-globulin (6). As
pointed out in a recent review by the Environmental
Protection Agency (7), this male-rat-specific protein
selectively binds certain chemicals or their metabo-
lites, is freely filtered by the glomerulus, and is
resorbed by the proximal tubule ofthe nephron, where
it accumulates in cellular lysosomes. The lysosomal
digestion ofthe chemical-protein complex is decreased
compared to a2u-globulin alone, leading to a marked
accumulation and subsequent cytotoxicity. In response
to cell death, cell replication is specifically enhanced.
What is important in the d-limonene study is the fact
that the presence of initiated cells in control animals
was clearly demonstrated. Control animals have large
numbers of atypical tubules, the first recognizable
focus of initiated cells. Atypical tubules are present in
Fischer rats and NBR rats in similar numbers (Table
2). Thus, there is not a strain difference in spontaneous
initiation. Identifying these early lesions requires per-
fusing the kidney and looking at six sections per kid-
ney. It is not necessary to initiate these animals with a
genotoxic chemical to demonstrate that d-limonene
causes a statistically significant increase in the number
of these initiated cells in F344 rats, but not in NBR
rats. Note that promotion of these lesions only occurs
under conditions where increased cell proliferation is
present. Neither increased cell proliferation nor pro-
motion of these spontaneously initiated cells occurs
when ot2u-globulin is not synthesized.
The same phenomenon is evident in more advanced
lesions. The number of atypical hyperplasias in all
groups is less than the number of atypical tubules.
These studies were conducted for 32 weeks; however,
it is likely that the numbers of preneoplastic lesions
would continue to increase throughout the life span of
the animal. Only small numbers ofthese lesions can be
demonstrated in control rats of either strain. When
F344 rats are treated with d-limonene, a statistically
significant increase in atypical hyperplasia occurs.
Again, promotion only occurs when sustained increas-
es in cell proliferation are present. This provides
Table 2. d-Limonene-induced cell proliferation and promotion in kidney (6).
Labeling Atypical Atypical
Exposure group Strain index tubules hyperplasia Adenomas
H20-corn oil F344 4.6 ± 0.3 3.3 ± 0.7 0.0 ± 0.0 0/31
H20-d-limonene F344 24.2 ± 1.5 10.7 ± 1.3 0.4 ± 0.1 0/31
EHEN-corn oil F344 5.2 ± 0.4 15.6 ± 1.5 1.2 ± 0.2 1/31
EHEN-d-limonene F344 20.5 ± 1.3 65.0 ± 3.4 15.5 ± 1.5 9/31
H20-corn oil NBR 4.5 ± 0.3 4.7 ± 0.8 0.1 ± 0.1 0/30
H20-d-limonene NBR 4.7 ± 0.2 4.6 ± 0.8 0.1 ± 0.0 0/31
EHEN-corn oil NBR 5.2 ± 0.4 9.6 ± 1.2 0.2 ± 0.1 0/30
EHEN-d-limonene NBR 5.6 ± 0.4 8.0 ± 1.0 0.2 ± 0.1 0/31
EHEN: N-ethyl-N-hydroxyethylnitrosamine.
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strong support for the concept that cell proliferation is
causal for the induction ofneoplasms for some chemical
carcinogens. Exposure to genotoxic agents, such as in
the EHEN-initiated groups in this study (6) further
magnifies the response.
We can summarize the role of cell proliferation in
carcinogenesis in the following way: a) Increased cell
proliferation decreases the time that is available for
DNA repair. This is a first principle that is not up for
debate. b) DNA replication converts repairable DNA
damage into nonrepairable mutations. Support for this
comes from numerous experiments in cell culture, as
well as from in vivo systems. c) Cell replication and
DNA synthesis are also necessary for chromosomal
aberrations, insertions, deletions, and gene amplifica-
tion, which are important mechanisms in chemical
carcinogenesis. d) Cell proliferation is required to clon-
ally expand initiated cell populations. An important
point is that a mutated Rb or mutated p53 gene prod-
uct increases cell proliferation, decreasing time avail-
able for repair. This eliminates one ofthe cell's impor-
tant check points and contributes to genomic instability.
The mechanisms that I have discussed for sustained
increases in cell proliferation are therefore similar to
what happens when the p53 or Rb gene is inactivated,
i.e., increased cell proliferation. Why is it acceptable
that aflatoxin's induction of point mutations at codon
249 of p53 is a mechanism that is causally related to
carcinogenesis and results in increased cell prolifera-
tion, but when cell proliferation is induced by other
means it is deemed an unlikely mechanism for carcino-
genesis? Such a rationale lacks scientific objectivity.
Likewise, to accept that cell proliferation alone is a pri-
mary mechanism for some nongenotoxic agents is total-
ly different from making generalizations that cell prolif-
eration is the mechanism for all MTD carcinogens.
There are no datathat support such ageneralization.
Not all agents that increase cell proliferation are car-
cinogens. There are many reasons why all chemicals
that cause increases in cell proliferation are not car-
cinogens: The first ofthese and no doubt the most com-
mon is related to the quality of the data being cited.
Transient increases in cell proliferation are common
responses to the administration ofmany chemicals, but
these do not provide sufficient evidence for or against
a causal link between cell proliferation and cancer.
Evidence of sustained increases in cell proliferation
that are not associated with increases in neoplasia is,
on the other hand, much less available, but must be
seriously considered. The exact temporal association
between increased cell proliferation and the induction
of neoplasia is unknown at this time. It is clear from
the data presented at this meeting on formaldehyde
that a minimum of3 months ofsustained cell prolifera-
tion is needed to sharply increase the slope for nasal
cancer incidence (5). Likewise, it took 12 months for
the nongenotoxic agent ethyl acrylate to induce
forestomach tumors in rats (8). Studies on a series of
jet fuels that induce oc2-globulin nephropathy demon-
strated that none of the fuels induced renal tumors
when male rats were exposed for 90 days and then
held for an additional 21 months, although several did
induce kidney tumors when the exposures were for 12
months and the rats were held for an additional 12
months (7). Thus, it is likely that sustained increases in
cell proliferation are required to induce carcinogenesis.
If examples are found where sustained increases are
present and no increase in neoplasia occurs, these will
be excellent examples to pursue to better understand
the critical mechanisms that are involved. Possible
examples include the ua2u-nephropathy-inducing agent
gabapentin (9).
The third factor that could explain the lack ofneopla-
sia in the presence of increased cell proliferation is
selective cytotoxicity of initiated cells. Before this
meeting, this mechanism seemed plausible, in that it
represented the reverse of the Solt-Farber model for
haptocarcinogenesis. However, initiated cells are far
more susceptible to the cytotoxicity and apoptosis
induced by some agents (10). Likewise, terminal differ-
entiation ofproliferating cells would remove this popu-
lation ofinitiated cells from progressing to cancer. Two
additional mechanisms were presented at this meeting.
Different responses to cell-cell communication could
alter the carcinogenic response (11), and maturation
arrest could decrease the likelihood of these cells pro-
gressing to neoplasms (12). Thus, a clear area for
future research is to gain a better understanding of
why some agents that enhance cell proliferation are
carcinogenic, while others are not. The fact that not all
agents that enhance cell proliferation are carcinogens
does not negate enhanced cell proliferation as a causal
mechanism for other agents. As is clear from the argu-
ments presented above, the two situations are not
mutually exclusive.
How then can we begin to factor new data into the
risk assessment process? Data were presented at this
meeting where increased incidences of cancer were
only seen after animals were exposed to high doses ofa
nongenotoxic agent under conditions that result in
increased cell proliferation, while humans are exposed
to much lower doses. Likewise, the genotoxic agent
formaldehyde induced a markedly increased incidence
of nasal cancer under conditions that caused a similar
increase in cell proliferation, even though the molecu-
lar dose was linear over that portion of the exposure-
response curve and humans are only exposed to con-
centrations not associated with increased cell prolifera-
tion. This meeting did not discuss nonlinearities in
molecular dose; however, I mentioned vinyl chloride
and formaldehyde as two examples. It should be clear
that incorporating mechanistic data such as cell prolif-
eration and molecular dose does not automatically
reduce the risk assessment. When a chemical saturates
metabolic activation or exposure is to young children
whose tissues are rapidly proliferating, the risk is like-
ly to be greater.
At the IARC meeting on mechanisms held in June
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1991, it was clearly pointed out that mechanistic data
could increase or decrease the classification ofa chemi-
cal carcinogen. This is only appropriate. Risk assess-
ments should be modified if an agent exhibits large
species differences in response. An example of this is
thyroid-stimulating hormone (TSH)-mediated thyroid
tumors. This is a well-characterized example of the
role of cell proliferation in chemical carcinogenesis.
The normal means of maintaining hormonal homeosta-
sis involves a feedback system between the hypothala-
mus-pituitary gland and the thyroid. When circulating
thyroxin levels become low, the pituitary releases
TSH, which in turn stimulates hypertrophy and hyper-
plasia ofthe thyroid follicular cells to synthesize more
thyroxin. Exposure to some chemicals interferes with
the production or metabolism of thyroxin, leading to
sustained increases in TSH release and subsequent cell
proliferation. This increase in cell proliferation leads to
the induction ofthyroid neoplasia (13). The induction of
thyroid tumors could be completely ablated by feeding
the animals thyroxin. To show that such thyroid
tumors were due to chronic TSH stimulation ofthyroid
follicular cell replication, experiments done more than
a quarter-century ago used transplantable pituitary
tumors that secrete TSH to induce thyroid neoplasms
(14).
Perhaps the most important outcome ofthis meeting
is the identification of future research needs to clarify
the role of cell proliferation in carcinogenesis. It is
clear that we need to expand our database in several
directions. Future bioasssays should be designed in a
manner to provide much more and better data on cell
proliferation. Beginning with the subchronic studies,
cell proliferation can be used to help establish the MTD.
The data will be useful in understanding nonlinearities
in dose response and will establish the correlations for
increased cell proliferation and the induction or nonin-
duction of neoplasia. These studies will provide test
compounds for elucidating critical mechanisms in car-
cinogenesis. Understanding interactions between
species-, sex- and tissue-specific susceptibility factors
and cell proliferation in chemical carcinogenesis is
another major need. Why are some tissues susceptible
to cancer induction while others are not? Why is the
rat bladder susceptible to calculi-induced bladder can-
cer and the mouse bladder not? Once a series ofchemi-
cals that have an adequate database on cell prolifera-
tion is available, we may be able to identify elements of
the mutational spectra that are associated with back-
ground DNA damage and cell proliferation. If one can
identify the cell proliferation equivalent ofthe aflatox-
in-induced p53 mutation at codon 249, it may provide a
markerforproliferation-induced neoplasia.
Let me end by addressing one ofthe organizing com-
mittee's opening questions: Should cell proliferation be
used in risk assessment? This could also be restated as:
Can science replace the emperor's new clothes? We
have discussed the different degrees of rigor that are
present in experiments and experimental data sets on
cell proliferation. We should give equal thought to the
degree of rigor that is present in the mathematical
extrapolations of risk that are currently practiced.
What is their basis? Have they ever been validated,
and where they are taking us? Regulation is important
to human health, but it also does not come without
costs. These costs are many fold. Ifwe do a poorjob of
communicating the causes of human cancer to society,
we are not promoting the prevention and control of
cancer. If society equates cigarette smoking with the
"carcinogen ofthe week" because the risk assessments
all look alike, we as scientists involved in cancer con-
trol have failed. We must begin to incorporate knowl-
edge ofmechanism into the risk assessment process to
improve its accuracy. In this regard, cell proliferation
is one piece ofmechanistic data that should be evaluat-
ed for its impact on the dose response for carcinogene-
sis. It is clear that accurate risk assessments will be
required to identify and prioritize those health issues
ofgreatest importance.
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